Key Highlights

  • SCWorx (NASDAQ:WORX) traded at USD 2.18, up 6.34%, in pre-market trading on Tuesday, October 27, 2026. No announcement dated on or just before that day was identified; the latest was a customer agreement of Monday, October 19, 2026.
  • Unaudited first half 2026 revenue was about USD 1.45 million, against about USD 1.40 million, with gross profit up about 122% to USD 705,000 and a net loss of about USD 295,000, against USD 2.4 million.
  • The Nasdaq Hearings Panel approved continued listing on Friday, October 2, 2026, trading resumed on Wednesday, October 7, 2026 and the company is subject to a Panel Monitor, a one-year compliance watch, through Saturday, October 2, 2027.
  • Publicly held shares were only 549,092 as of Thursday, September 17, 2026, so liquidity is thin, and pre-market quotes can change before the open.

The Pre-Market Move and Its Catalyst

SCWorx (NASDAQ:WORX), a provider of data management and normalisation services for healthcare supply chains, traded at USD 2.18, up 6.34%, in pre-market trading on Tuesday, October 27, 2026. This is a pre-market snapshot, and prices can change before the open at 9:30 a.m. ET. No company-specific announcement dated on or just before Tuesday, October 27, 2026 accompanied the move. The most recent release, of Monday, October 19, 2026, announced an agreement with an independent, community-owned health system serving New Mexico, Arizona, Colorado and Utah, with financial terms not disclosed. The move appears consistent with continued interest after the return to trading on Wednesday, October 7, 2026 and with thin liquidity. Both readings are inferences.

How the Latest Results Frame the Move

Why the listing outcome matters is shown by the company's release of Wednesday, October 7, 2026, which gave unaudited first half 2026 figures. Revenue was about USD 1.45 million, against about USD 1.40 million a year earlier. Gross profit rose about 122% to USD 705,000, and the net loss narrowed to about USD 295,000 from USD 2.4 million. Cash used in operations was about USD 258,000, against USD 1.1 million, and cash was about USD 1.3 million at Tuesday, June 30, 2026. The company sold 350,000 units at USD 2.68 each on Thursday, September 17, 2026 for gross proceeds of about USD 938,000, with five-year warrants exercisable at USD 2.56. Proceeds are held in a segregated account until Monday, November 30, 2026.

Risks and What to Watch

The bull reading rests on higher gross profit, a much smaller loss and the restored listing, which followed a suspension of trading on Tuesday, April 14, 2026 for failing the USD 1.00 minimum bid price rule. The bear reading rests on revenue that is nearly flat, cash of about USD 1.3 million and a float of 549,092 shares, close to the 500,000 minimum. Named risks include dilution from the warrants, a renewed minimum bid breach under the Panel Monitor, which runs through Saturday, October 2, 2027, and dependence on a small number of healthcare customers. Closing bids have been at or above USD 1.00 since Tuesday, August 4, 2026. Investors should watch the release of the segregated proceeds on Monday, November 30, 2026, the third quarter results and the Federal Reserve decision on Wednesday, October 28, 2026.

Where Things Stand

The answer is that SCWorx (NASDAQ:WORX) rose 6.34% pre-market without a dated announcement, and the restored listing, the October 19 customer agreement and thin liquidity are the more consistent explanations. The key number is about USD 705,000 of first half gross profit, which rose about 122%, against a small float of 549,092 shares. The next catalysts are the third quarter report, for which no date has been announced, the end of the segregated proceeds period on Monday, November 30, 2026 and the Federal Reserve decision on Wednesday, October 28, 2026. Pre-market prices are snapshots and can change, and this is not investment advice.